MDT

83.88

-0.64%↓

VEEV

226.14

-0.65%↓

A

106

-0.63%↓

WBA

10.98

-0.36%↓

CHE

557.17

+1.84%↑

MDT

83.88

-0.64%↓

VEEV

226.14

-0.65%↓

A

106

-0.63%↓

WBA

10.98

-0.36%↓

CHE

557.17

+1.84%↑

MDT

83.88

-0.64%↓

VEEV

226.14

-0.65%↓

A

106

-0.63%↓

WBA

10.98

-0.36%↓

CHE

557.17

+1.84%↑

MDT

83.88

-0.64%↓

VEEV

226.14

-0.65%↓

A

106

-0.63%↓

WBA

10.98

-0.36%↓

CHE

557.17

+1.84%↑

MDT

83.88

-0.64%↓

VEEV

226.14

-0.65%↓

A

106

-0.63%↓

WBA

10.98

-0.36%↓

CHE

557.17

+1.84%↑

Search

AngioDynamics Inc

Deschisă

SectorSănătate

9.54 -0.63

Rezumat

Modificarea prețului

24h

Curent

Minim

9.13

Maxim

9.66

Indicatori cheie

By Trading Economics

Venit

6.3M

-4.4M

Vânzări

-841K

72M

EPS

-0.08

Marjă de profit

-6.12

Angajați

748

EBITDA

-2.1M

-329K

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+65.78% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-8.8M

376M

Deschiderea anterioară

10.17

Închiderea anterioară

9.54

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

AngioDynamics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 dec. 2024, 15:23 UTC

Principalele dinamici ale pieței

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 dec. 2024, 15:20 UTC

Principalele dinamici ale pieței

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Comparație

Modificare preț

AngioDynamics Inc Așteptări

Obiectiv de preț

By TipRanks

65.78% sus

Prognoză pe 12 luni

Medie 15.5 USD  65.78%

Maxim 16 USD

Minim 15 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAngioDynamics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

2

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

9.4553 / 9.76Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.